Search for: "Finnegan, Henderson, Farabow, Garrett, "
Results 101 - 120
of 309
Sorted by Relevance
|
Sort by Date
10 Oct 2021, 9:55 pm
Frank DeCosta of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Andrea Lynn Evensen of Siemens Corporation; and Brian Welle of IBM will walk through an invention disclosure to discuss strategies and best practices for protecting, licensing, and enforcing IP rights covering AI. [read post]
12 Jul 2013, 8:44 pm
Shaffer of Finnegan Henderson Farabow Garrett & Dunner provide patent counsel with guidance on claim and label language; to proactively coordinate patent, regulatory and clinical personnel; and to maintain consistency between claims and likely or actual label language throughout patent prosecution and label negotiation with the FDA. [read post]
2 Jan 2023, 9:34 pm
Raich, and Yieyie Yang of Finnegan Henderson Farabow Garrett & Dunner will guide attendees on the Biologics Price Competition and Innovation Act (BPCIA), discuss the Purple Book and issues related to exclusivities and the retroactivity of the BPCIA, address the ongoing debate over whether the BPCIA's patent dispute resolution procedures are allowed or required and the litigation that... [read post]
2 Mar 2019, 9:46 pm
MacAlpine of Finnegan Henderson Farabow Garrett & Dunner will guide IP counsel for understanding double patenting, analyze recent court treatment, including two significant Federal Circuit decisions, offer best practices to defeat double patenting rejections and avoid terminal disclaimers, and provide specific language to consider if a terminal disclaimer must be filed. [read post]
22 Nov 2013, 9:34 pm
Amanda Murphy of Finnegan Henderson Farabow Garrett & Dunner will provide patent counsel with a review of the benefits and limitations in using means-plus-function claims in pursuing a patent, and offer their experiences and best practices for overcoming the challenges of means-plus-function claims and leveraging Section 112(f) (aka 112, 6). [read post]
24 Jun 2017, 9:06 pm
Bell of Finnegan Henderson Farabow Garrett & Dunner will provide patent counsel with an analysis of the ever-increasing number of Patent Trial and Appeal Board (PTAB) denials and partial denials and offer take-home lessons applicable in practitioners' daily practice. [read post]
31 Oct 2021, 9:10 pm
Sabine Age of Hoyng Rokh Monegier will moderate a panel consisting of Patrick Coyne of Finnegan, Henderson, Farabow, Garrett & Dunner LLP; Kevin Duan of Han Kun Law; Dina Kallay of Ericsson; Bill MacLeod of Kelley Drye & Warren LLP; and Barry Nigro of Fried, Frank, Harris, Shriver & Jacobson LLP. [read post]
5 Jan 2019, 4:25 pm
Flibbert of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on preparing a PTAB case for appeal to the Federal Circuit, and also offer strategic tips for conducting a PTAB trial with an eye to appeal and best practices for prevailing on appeal. [read post]
16 Jan 2021, 9:58 pm
Tom Irving of Finnegan of Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Daniela Gill-Carey of UCB Biopharma, Sarah Hooson of Merck, and Margaret Tomaska of Eli Lilly and Co. [read post]
24 Jan 2014, 8:50 pm
., of Finnegan Henderson Farabow Garrett & Dunner and Lauren L. [read post]
19 Sep 2014, 9:27 pm
Herzfeld of Finnegan Henderson Farabow Garrett & Dunner; and Donna M. [read post]
29 Jan 2022, 7:36 pm
Puknys of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Peter Marksteiner, Circuit Executive and Clerk of Court, U.S. [read post]
12 Jul 2013, 8:46 pm
Rudolph of Finnegan Henderson Farabow Garrett & Dunner LLP will moderate a panel that includes Jennifer L. [read post]
6 Oct 2018, 9:31 pm
Bryan Diner of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP; Brian Nolan of Mayer Brown LLP; and James Trainor of Fenwick & West LLP will look at the nature of legal traps that can lurk in prosecution history, caused both by disclaimers and amendments, and how they can snare defendants or plaintiffs in infringement litigation. [read post]
30 Apr 2016, 8:24 pm
., of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on how to maximize the impact of a Patent Owner Preliminary Response (POPR), in light of the PTAB final rules, and discuss insufficient evidence in the petition, favorable claim constructions, and attacking threshold issues. [read post]
12 May 2018, 9:24 pm
Rudolph of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on two recent Supreme Court patent decisions. [read post]
27 May 2018, 8:42 pm
Tull of Finnegan Henderson Farabow Garrett & Dunner will guide counsel for companies in the medical device industry on protecting software as a medical device (SaMD), and discuss the new FDA rules regulating SaMD and how to leverage IP law to protect SaMD. [read post]
15 Aug 2014, 9:12 pm
Herzfeld of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on leveraging decisions by the Court of Customs and Patent Appeals (CCPA) and the Federal Circuit in the application of the Section 103 obviousness standard and offer strategies for evaluating obviousness,... [read post]
8 Nov 2013, 8:24 pm
Jessica Marks of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Dr. [read post]
7 May 2016, 7:10 pm
McDonell of Finnegan Henderson Farabow Garrett & Dunner will examine the determination of challenging patent applications pre-grant and the factors that should be considered when making the decision to challenge, and discuss preissuance submissions of relevant prior art, protests and derivation proceedings as well as the risks and ramifications of challenging pending patent applications.... [read post]
